1. Home
  2. MYND vs BRNS Comparison

MYND vs BRNS Comparison

Compare MYND & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mynd.ai Inc.

MYND

Mynd.ai Inc.

HOLD

Current Price

$0.47

Market Cap

28.3M

Sector

Real Estate

ML Signal

HOLD

Logo Barinthus Biotherapeutics plc

BRNS

Barinthus Biotherapeutics plc

HOLD

Current Price

$0.72

Market Cap

55.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYND
BRNS
Founded
1998
2016
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.3M
55.9M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
MYND
BRNS
Price
$0.47
$0.72
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
10.8K
70.5K
Earning Date
08-27-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$209,800,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1766.46
52 Week Low
$0.45
$0.64
52 Week High
$2.77
$2.92

Technical Indicators

Market Signals
Indicator
MYND
BRNS
Relative Strength Index (RSI) 28.99 43.33
Support Level $0.50 $0.68
Resistance Level $0.59 $0.78
Average True Range (ATR) 0.06 0.06
MACD -0.01 0.02
Stochastic Oscillator 21.74 58.02

Price Performance

Historical Comparison
MYND
BRNS

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Share on Social Networks: